1The CT Lamont Centre, Élisabeth-Bruyère Research Institute, Ottawa. 2The Division of Geriatric Medicine, Department of Internal Medicine, University of Ottawa. 3The Clinical Epidemiology Program, the University of Ottawa Health Research Institute, Ottawa. 4DementiaNET—a CIHR New Emerging Team. 5The Department of Epidemiology and Community Medicine, University of Ottawa. 6Regional Geriatric Program of Eastern Ontario.
Objective: To derive and validate simple screens of 2 to 4 questions to identify cognitive impairment.
Design: Cross-sectional database analysis.
Setting and Participants: Community-dwelling participants in the Canadian Study of Health and Aging with mild to moderate cognitive impairment (N = 958), or normal cognition (N = 602).
Measurements: Cognitive questions not requiring paper, pen, cue cards, props or more than 30 seconds to answer were selected from the Modified Mini-Mental State Examination (3MS). A sequential weighting approach was applied to logistic regression analyses to create scales of equally-weighted questions using the first 2, 3 or 4 questions from the regression equations.
Sensitivities and specificities were calculated for all cutoffs. Two sets of questions, which approximated the psychometric properties of the 3MS, were validated in a second database.
Results: The two tests whose properties approached those of the 3MS (sensitivity 84%, specificity 62%) were the Ottawa
3D test: Day, Date, DLROW (sensitivity 76%, specificity 62%) and the Ottawa 3DY test: Day, Date, DLROW, Year (sensitivity 80%, specificity 61%).
Conclusions: The Ottawa 3D and 3DY tests show promising psychometric properties and are easy enough to employ to promote widespread use but must be revalidated in the target groups for which they are intended.
The full potential value of the Ottawa 3D and 3DY tests can best be understood in the context of ‘serial trichotomization’ cognitive screening or case-finding algorithms. Dementia researchers focusing on biomarkers and neuroimaging should consider similar trichotomization approaches as these may improve the sensitivities and specificities of their tests.
PDF (307.06 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
We have had a fantastic and unprecedented experience publishing our paper in Clinical Medicine Insights: Oncology. The process of submitting and correcting the proofs were simple, quick, and smooth. We appreciated the clarity and easiness of instructions and your fast responses to our emails. Great work. Keep it up.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2014 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)